Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.021 | 0.9 |